Cogstate Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Cogstate kazanç ve gelirin sırasıyla yıllık 12.1% ve 7.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 12.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 20.2% olacağı tahmin edilmektedir.

Anahtar bilgiler

12.1%

Kazanç büyüme oranı

12.40%

EPS büyüme oranı

Healthcare Services kazanç büyümesi	22.8%
Gelir büyüme oranı	7.3%
Gelecekteki özkaynak getirisi	20.15%
Analist kapsamı	Low
Son güncelleme	27 Aug 2025

Gelecekteki son büyüme güncellemeleri

Cogstate Limited Beat Revenue Forecasts By 9.5%: Here's What Analysts Are Forecasting Next

Feb 21

Recent updates

Earnings Not Telling The Story For Cogstate Limited (ASX:CGS) After Shares Rise 27%

Sep 26

Cogstate (ASX:CGS) Is Very Good At Capital Allocation

Aug 05

Cogstate Limited's (ASX:CGS) 31% Price Boost Is Out Of Tune With Earnings

Jul 18

Cogstate Limited Beat Revenue Forecasts By 9.5%: Here's What Analysts Are Forecasting Next

Feb 21

Reacquisition Of Eisai IP Will Unlock New Markets For Clinical Trials

Feb 11 Diversification into new indications and reacquisition of IP expand market opportunities, enhance revenue potential, and reduce dependency on single areas.

Cogstate Limited (ASX:CGS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Dec 14

Pinning Down Cogstate Limited's (ASX:CGS) P/E Is Difficult Right Now

Aug 30

There's Been No Shortage Of Growth Recently For Cogstate's (ASX:CGS) Returns On Capital

Jul 26

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Mar 23

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

Mar 02

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Jan 13

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Oct 04

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Sep 28

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Sep 02

We Ran A Stock Scan For Earnings Growth And Cogstate (ASX:CGS) Passed With Ease

Jun 30

Investors Should Be Encouraged By Cogstate's (ASX:CGS) Returns On Capital

Mar 22

We Think Some Shareholders May Hesitate To Increase Cogstate Limited's (ASX:CGS) CEO Compensation

Oct 20

Cogstate (ASX:CGS) Is Looking To Continue Growing Its Returns On Capital

Jul 23

Is Cogstate (ASX:CGS) Using Too Much Debt?

Apr 29

Kazanç ve Gelir Büyüme Tahminleri

ASX:CGS - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2028	66	14	13	15	2
6/30/2027	62	12	12	14	2
6/30/2026	58	10	11	14	2
6/30/2025	53	10	8	11	N/A
3/31/2025	50	9	9	11	N/A
12/31/2024	47	7	9	11	N/A
9/30/2024	45	6	7	9	N/A
6/30/2024	43	5	4	6	N/A
3/31/2024	42	5	1	3	N/A
12/31/2023	41	6	-1	0	N/A
9/30/2023	41	5	-1	1	N/A
6/30/2023	40	4	-2	1	N/A
3/31/2023	41	4	1	4	N/A
12/31/2022	41	3	4	8	N/A
9/30/2022	43	6	5	9	N/A
6/30/2022	45	8	6	10	N/A
3/31/2022	43	9	4	7	N/A
12/31/2021	42	10	2	4	N/A
9/30/2021	37	7	8	10	N/A
6/30/2021	33	5	13	16	N/A
3/31/2021	30	3	12	16	N/A
12/31/2020	28	0	11	15	N/A
9/30/2020	25	-1	4	8	N/A
6/30/2020	23	-2	-2	1	N/A
3/31/2020	21	-3	-3	0	N/A
12/31/2019	19	-3	-4	-2	N/A
9/30/2019	21	-3	-3	-1	N/A
6/30/2019	22	-2	-3	0	N/A
3/31/2019	24	-2	N/A	1	N/A
12/31/2018	27	-1	N/A	2	N/A
9/30/2018	28	-1	N/A	1	N/A
6/30/2018	29	-1	N/A	0	N/A
3/31/2018	27	-2	N/A	-1	N/A
12/31/2017	26	-3	N/A	-2	N/A
9/30/2017	26	-2	N/A	0	N/A
6/30/2017	26	-1	N/A	2	N/A
3/31/2017	26	0	N/A	3	N/A
12/31/2016	24	1	N/A	4	N/A
9/30/2016	23	1	N/A	3	N/A
6/30/2016	20	2	N/A	2	N/A
3/31/2016	19	1	N/A	1	N/A
12/31/2015	17	0	N/A	-1	N/A
9/30/2015	14	-2	N/A	-1	N/A
6/30/2015	12	-4	N/A	-2	N/A
3/31/2015	11	-3	N/A	-2	N/A
12/31/2014	10	-3	N/A	-2	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CGS 'nin tahmini kazanç büyümesi (yıllık 12.1% ) tasarruf oranının ( 3.1% ) üzerindedir.

Kazançlar ve Piyasa: CGS şirketinin kazançlarının (yıllık 12.1% ) Australian pazarından (yıllık 11.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: CGS şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: CGS şirketinin gelirinin (yıllık 7.3% ) Australian pazarından (yıllık 5.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: CGS şirketinin gelirinin (yıllık 7.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: CGS 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 20.2 %)

Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/10/05 19:13
Gün Sonu Hisse Fiyatı	2025/10/03 00:00
Kazançlar	2025/06/30
Yıllık Kazançlar	2025/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Cogstate Limited 2 Bu analistlerden 2, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Elyse Shapiro	Canaccord Genuity
Dennis Hulme	Taylor Collison Limited

Cogstate Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus revenue estimates increase by 11%

Cogstate Limited Provides Earnings Guidance for the Second Half and Full Year Ending June 30, 2025

Cogstate Limited Beat Revenue Forecasts By 9.5%: Here's What Analysts Are Forecasting Next

Cogstate Limited Provides Financial Guidance for the Fiscal Year 2025

Consensus revenue estimates decrease by 10%, EPS upgraded

Price target decreased by 8.1% to AU$1.70

Recent updates

Earnings Not Telling The Story For Cogstate Limited (ASX:CGS) After Shares Rise 27%

CEO, MD & Executive Director recently bought AU$87k worth of stock

Full year 2025 earnings released: EPS: US$0.059 (vs US$0.032 in FY 2024)

Consensus revenue estimates increase by 11%

Cogstate Limited announces Annual dividend, payable on September 29, 2025

Cogstate (ASX:CGS) Is Very Good At Capital Allocation

Cogstate Limited, Annual General Meeting, Oct 16, 2025

Cogstate Limited's (ASX:CGS) 31% Price Boost Is Out Of Tune With Earnings

CEO, MD & Executive Director exercised options to buy AU$1.4m worth of stock.

Cogstate Limited Provides Earnings Guidance for the Second Half and Full Year Ending June 30, 2025

Investor sentiment improves as stock rises 26%

Cogstate Limited to Report Fiscal Year 2025 Results on Aug 22, 2025

Now 24% overvalued after recent price rise

Now 21% overvalued after recent price rise

First half 2025 earnings released: EPS: US$0.023 (vs US$0.012 in 1H 2024)

Cogstate Limited Beat Revenue Forecasts By 9.5%: Here's What Analysts Are Forecasting Next

Investor sentiment improves as stock rises 19%

Reacquisition Of Eisai IP Will Unlock New Markets For Clinical Trials

Cogstate Limited to Report First Half, 2025 Results on Feb 20, 2025

Cogstate Limited (ASX:CGS) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Investor sentiment improves as stock rises 15%

Cogstate Appoints Kaycee Sink as Chief Medical Officer

CEO, MD & Executive Director exercised options to buy AU$965k worth of stock.

New minor risk - Market cap size

Pinning Down Cogstate Limited's (ASX:CGS) P/E Is Difficult Right Now

Non-Executive Chairman recently bought AU$108k worth of stock

Full year 2024 earnings: EPS exceeds analyst expectations

Cogstate Limited Provides Financial Guidance for the Fiscal Year 2025

Consensus revenue estimates decrease by 10%, EPS upgraded

There's Been No Shortage Of Growth Recently For Cogstate's (ASX:CGS) Returns On Capital

If EPS Growth Is Important To You, Cogstate (ASX:CGS) Presents An Opportunity

First half 2024 earnings released: EPS: US$0.012 (vs US$0 in 1H 2023)

Price target decreased by 8.1% to AU$1.70

Investor sentiment deteriorates as stock falls 17%

The Price Is Right For Cogstate Limited (ASX:CGS)

Cogstate Limited to Report First Half, 2024 Results on Feb 22, 2024

Price target increased by 8.6% to AU$1.85

Cogstate Limited Provides Revenue Guidance for 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Is Cogstate Limited (ASX:CGS) Trading At A 29% Discount?

Now 21% undervalued

Price target decreased by 9.0% to AU$1.70

Now 23% undervalued

Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023

Consensus EPS estimates increase by 12%

Returns Are Gaining Momentum At Cogstate (ASX:CGS)

Growth Investors: Industry Analysts Just Upgraded Their Cogstate Limited (ASX:CGS) Revenue Forecasts By 11%

Consensus revenue estimates increase by 11%

Investor sentiment deteriorates as stock falls 16%

CEO, MD & Executive Director recently bought AU$100k worth of stock

Earnings Update: Cogstate Limited (ASX:CGS) Just Reported And Analysts Are Trimming Their Forecasts

First half 2023 earnings released: EPS: US$0 (vs US$0.024 in 1H 2022)

Consensus EPS estimates increase by 23%, revenue downgraded

Investor sentiment deteriorates as stock falls 25%

Now 24% undervalued

Cogstate Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 22% undervalued

Cogstate Limited Announces Resignation of David Dolby as Non-Executive Director

Cogstate Limited (ASX:CGS) Shares Could Be 19% Below Their Intrinsic Value Estimate

Price target decreased to AU$1.92

High number of new and inexperienced directors

Investors Appear Satisfied With Cogstate Limited's (ASX:CGS) Prospects As Shares Rocket 51%

Do Cogstate's (ASX:CGS) Earnings Warrant Your Attention?

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Returns On Capital Are A Standout For Cogstate (ASX:CGS)

Price target decreased to AU$2.18

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to AU$2.41